The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis

Background: It seems that patients with multiple sclerosis (MS) are at a higher risk for coronavirus disease 2019 (COVID-19) implications due to being subjected to immunomodulatory or immunosuppressive treatments. Besides, obesity as a risk factor may lead to more adverse consequences. The relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaeimanesh, Nasim, Abbasi, Naghmeh, Sahraian, Mohammad Ali, Azimi, Amirreza, Razeghi-Jahromi, Soodeh, Moghadasi, Abdorreza Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444594/
https://www.ncbi.nlm.nih.gov/pubmed/38011335
http://dx.doi.org/10.18502/cjn.v22i1.12613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444594/
https://www.ncbi.nlm.nih.gov/pubmed/38011335
http://dx.doi.org/10.18502/cjn.v22i1.12613

Ejemplares similares